Jackson S H, Pickles H
Eur J Clin Pharmacol. 1983;25(3):303-5. doi: 10.1007/BF01037938.
Indomethacin 100 mg/day or matching placebo was given for 2.5 days to 9 healthy volunteers in a double-blind cross-over study, followed by an intravenous injection of 0.2 mg/kg of hydralazine. Compared to placebo, indomethacin produced no statistically significant change in pulse rate or blood pressure in both standing and supine positions. Hydralazine injection was followed by a statistically significant fall in lying and standing diastolic pressure and a rise in lying and standing pulse after both indomethacin and placebo pretreatments. There were no significant differences in these effects following indomethacin compared to placebo pretreatment. These results do not support the hypothesis that endogenous prostaglandins are involved in the mechanism of action of hydralazine.
在一项双盲交叉研究中,给9名健康志愿者服用100毫克/天的吲哚美辛或匹配的安慰剂,持续2.5天,随后静脉注射0.2毫克/千克的肼屈嗪。与安慰剂相比,吲哚美辛在站立和仰卧位时的脉搏率或血压均未产生统计学上的显著变化。在吲哚美辛和安慰剂预处理后,注射肼屈嗪后,仰卧和站立时的舒张压均出现统计学上的显著下降,仰卧和站立时的脉搏均升高。与安慰剂预处理相比,吲哚美辛预处理后这些效应无显著差异。这些结果不支持内源性前列腺素参与肼屈嗪作用机制的假说。